welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
Kevin P. Campbell, PhD
Chair and Department Executive Officer
Department of Molecular Physiology and Biophysics
University of Iowa
200 Hawkins Drive
Iowa City, Iowa, United States
Dr. Campbell is an Investigator for the Howard Hughes Medical Institute and a Professor of Molecular Physiology and Biophysics at the University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City. He received his B.S. degree in physics from Manhattan College, his master’s degree from the University of Rochester School of Medicine and Dentistry, and his Ph.D. in Biophysics from the Department of Radiation Biology and Biophysics at the University of Rochester. He did postdoctoral studies in the laboratory of Dr. David MacLennan at the Banting and Best Department of Medical Research, University of Toronto, before moving to Iowa in 1981.
Kevin Campbell is internationally known for his neuromuscular disease research. He directs the Wellstone Muscular Dystrophy Cooperative Research Center at the University of Iowa. Dr. Campbell is also a professor of internal medicine and neurology.
Dr. Campbell’s work has led to the identification of the molecular and genetic basis of several forms of muscular dystrophy including Duchenne muscular dystrophy and provided a clearer understanding of muscular dystrophy disease processes. Dr. Campbell’s findings have already greatly improved the diagnosis of muscular dystrophy, and they point to strategies for developing therapies for these devastating inherited neuromuscular diseases.
He serves on the Scientific Advisory Board of CureDuchenne.
Pharmaceutical partners invest $6M in Eloxx to advance therapy for Duchenne MDEloxx Pharmaceuticals received a $6 mill...
Jerry R. Mendell, MDJerry R. Mendell, MD, is an attending ne...
Thomas Voit, MD, PhDDr. Thomas Voit is the Director of the B...
Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular DystrophyInvestigator researched that the effect ...
Sarepta Therapeutics and Genethon announce a gene therapy research collaboration for the treatment of Duchenne muscu...Sarepta Therapeutics, Inc. (NASDAQ:SRPT)...
Lauren Cozma, PT...
Nathalie Goemans, MD, PhDDr. Nathalie Goemans is the head of the ...